The global microbiology culture market was valued at USD 9.60 Billion in 2025 and is expected to grow at a CAGR of 6.90%, reaching USD 18.71 Billion by 2035. The market is advancing worldwide as early pathogen detection, quality control, and disease monitoring become critical healthcare priorities. The increasing pharmaceutical R&D, the growth of food microbiology testing, and wider adoption of automated identification platforms are boosting demand for diverse culture media across clinical, industrial, and research-based applications.
Base Year
Historical Period
Forecast Period
In May 2025, BiomatiQ’s inauguration of its fully automated RTU culture media facility strengthened high-quality, contamination-free production, enhancing efficiency and reliability, directly accelerating growth in the market.
The expansion of high-quality ready-to-use culture media is a key trend shaping the market. For instance, in April 2025, AnalytiChem globally introduced its Redipor® prepared media line, enhancing reliability and efficiency, thereby boosting microbiology culture market growth.
The market is expanding rapidly due to rising infectious disease testing, technological advancements, and growing lab automation, while major industry players drive innovation, product availability, and global adoption, collectively accelerating overall market growth.
Compound Annual Growth Rate
6.9%
Value in USD Billion
2026-2035
*this image is indicative*
Microbiology culture contributes significantly to scientific progress by enabling accurate microbial investigation for clinical, industrial, and research applications worldwide. The market is poised to grow at a CAGR of 6.90% during the forecast period of 2026-2035. It is advancing as regional laboratories modernize diagnostic operations and strengthen disease monitoring initiatives. Increasing healthcare expenditure, rising laboratory automation, and growing reliance on culture-based techniques are supporting consistent market expansion throughout the region.
Strategic Investments in Microbial Production Expected to Drive Growth in the Market
The establishment of advanced microbial production facilities is a key driver of growth in the market. In October 2025, HIPRA inaugurated its Bacterial Culture Unit (CB6) at the Aiguaviva campus, featuring cutting-edge technologies to enhance the development and manufacturing of biotechnological vaccines. The 5,570 m² facility, operating under BSL2+ biosafety standards, specializes in producing antigens and recombinant proteins using microbial systems, including bacteria, mycoplasmas, and yeasts. Such strategic investment underscores the increasing adoption of advanced microbial culture technologies, reinforcing sustained market growth and fostering innovation.
The market is witnessing several trends, including the increasing adoption of certified cell culture media and the expansion of strategic partnerships to advance cell analysis solutions.
Rising Adoption of Certified Cell Culture Media to Accelerate the Market Demand
The market is witnessing a notable shift towards high-quality, certified cell culture media to meet stringent biopharmaceutical manufacturing standards. In September 2024, Merck became the first company in the industry to receive EXCiPACT cGMP certification for its cell culture media production sites across Germany, the United Kingdom, China, and the United States. This certification underscores the emphasis on safety, quality, and efficacy in biomanufacturing, particularly for vaccines, gene therapies, and monoclonal antibodies. Such advancements in certified media are expected to enhance reliability and drive sustained growth in the microbiology culture market globally.
Growing Strategic Partnerships to Drive Advanced Cell Analysis Solutions and Boost the Microbiology Culture Market Value
The strategic collaborations between technology providers to introduce innovative cell analysis solutions are a growing trend shaping the market. In February 2024, Cell Microsystems partnered with OMNI Life Science to launch advanced products, including the CERO 3D Cell Culture Incubator & Bioreactor, CASY Cell Counter and Analyzer, and TIGR Tissue Grinder & Dissociator. This partnership exemplifies the integration of cutting-edge tools that enhance cell culture, analysis, and tissue processing capabilities. Such collaborations are expected to accelerate research efficiency and bolster market growth in the microbiology culture sector.
Culture Media Expected to Lead the Market Share by Product
The market comprises key products, including culture media, instruments, and reagents & consumables, all essential for laboratory research and biopharmaceutical applications. Among these, culture media is expected to lead the market due to its critical role in supporting cell growth, research reproducibility, and advanced therapeutic development. The segment’s growth is driven by rising demand for high-quality, standardized media that ensures consistency and safety in experiments. In January 2025, Nucleus Biologics became the first custom cell culture media company to achieve EXCiPACT certification for Excipient GMP quality media, supplements, and buffers, highlighting the increasing focus on regulatory compliance and quality in cell and gene therapy applications. This positions culture media as the primary contributor to market growth in the coming years.
The market is divided into regions such as North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. Among these, North America is emerging as a signifincat region due to advanced research infrastructure, high healthcare investment, and increasing focus on innovative microbial studies. In August 2025, a student researcher at Bemidji State University, Minnesota, discovered a novel bacteriophage named “Jant” capable of targeting Mycobacterium species, including those related to tuberculosis. This breakthrough underscores North America’s strong position in microbiology research, emphasizing cutting-edge phage therapy potential, academic-industry collaboration, and robust scientific innovation in microbial culture technologies.
The key features of the market report include funding and investment analysis and strategic initiatives by leading players. The major companies in the market are as follows:
Merck KGaA, a worldwide leader in laboratory technologies, maintains a dominant presence in the market through its comprehensive portfolio for pathogen and indicator organism testing. Its innovative ReadyStream® concentrated media system, which prepares and dispenses pre-heated culture media on demand, supports high-throughput laboratories conducting routine testing for Salmonella, coliforms, and other critical microorganisms. This technology enhances operational efficiency, reduces waste, and accelerates microbiological investigations across global pharmaceutical, food, and environmental testing facilities
Thermo Fisher Scientific Inc., a worldwide leader in laboratory technologies, continues to influence the market with its robust Atmosphere Generation Systems, engineered to create precise anaerobic and microaerophilic environments for organism growth. These systems enable laboratories to cultivate demanding microorganisms with greater accuracy and reduced variability. With its long-standing commitment to microbial process reliability, the company supports global research institutions, pharmaceutical manufacturers, and clinical testing centers in achieving high-quality and reproducible culture outcomes.
Becton, Dickinson and Company (BD), a worldwide leader in clinical and laboratory technologies, remains significant in the microbiology culture market through its BD Synapsys™ Informatics Solution. This cybersecure, integrated platform unifies blood culture-related data from multiple instruments and locations, transforming them into actionable insights for laboratory teams. By supporting workflow optimization, performance monitoring, and standardization, BD Synapsys™ strengthens global microbiology operations. Its analytics-driven approach enables healthcare institutions worldwide to manage cultures more efficiently and improve outcomes in bloodstream infection diagnostics
bioMérieux remains a prominent global innovator in microbiology, offering integrated solutions that elevate laboratory accuracy and efficiency worldwide. In the market, its cutting-edge Idea™ Stec agar provides targeted isolation and confirmation of Shiga toxin–producing Escherichia coli, addressing a major food safety concern at the international level. The agar’s high selectivity and optimized performance demonstrate bioMérieux’s commitment to advancing pathogen detection methods globally. Its continued scientific contributions help set modern standards for safety, reliability, and productivity in food microbiology testing
*Please note that this is only a partial list; the complete list of key players is available in the full report. Additionally, the list of key players can be customized to better suit your needs.*
Other key players in the market include Bio-Rad Laboratories, Corning Incorporated, TCS Biosciences, MP Biomedicals, Lab M, and Liofilchem (Microbio).
The market report offers a detailed analysis of the market based on the following segments:
Market Breakup by Product
Market Breakup by Type/ Media
Market Breakup by Application
Market Breakup by End User
Market Breakup by Region
Upto 15% Off
USD
$3299 $2969
$5499 $4949
$6999 $5949
$8199 $6969
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.
| REPORT FEATURES | DETAILS |
| Base Year | 2025 |
| Historical Period | 2019-2025 |
| Forecast Period | 2026-2035 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Product |
|
| Breakup by Type/Media |
|
| Breakup by Application |
|
| Breakup by End User |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
Datasheet
One User
USD 3,299
USD 2,969
tax inclusive*
Single User License
One User
USD 5,499
USD 4,949
tax inclusive*
Five User License
Five User
USD 6,999
USD 5,949
tax inclusive*
Corporate License
Unlimited Users
USD 8,199
USD 6,969
tax inclusive*
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Small Business Bundle
Growth Bundle
Enterprise Bundle
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
How To Order
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Share